A new study reveals a 15 per cent rise in adult ADHD diagnoses between 2020 and 2023, while teenage rates remain stable.

(RTTNews) - French drug major Sanofi (SNY) announced Monday that its Sarclisa has obtained first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma ...

including an increase among adults from 2020 to 2023. The study, published in the journal Psychiatric Research and Clinical Practice, found a significant downward trends in ADHD incidence among ...

We have updated our weighting methodology to improve comparability of our smoking prevalence estimates for 2020 and subsequent years. For more details about this update, see our Adult smoking habits ...

In 2023, 42% of adults were unpartnered, down from 44% in 2019. The decline in the share of adults who are unpartnered since ...